Amgen Acquires KAI Pharmaceuticals

Amgen Acquires KAI Pharmaceuticals

Acquisition holds opportunity to potentially deliver novel therapy for chronic kidney disease patients on dialysis suffering from secondary hyperparathyroidism

Specificity by Ring Size

Specificity by Ring Size

Bicyclic peptides with optimized ring size inhibit enzyme that cleaves peptide bonds while sparing paralogous proteases

Nano Magnets Enter the Brain

Nano Magnets Enter the Brain

Nano magnets conjugated to lactoferrin cross the blood-brain barrier opening up diagnostic and therapeutic applications